In 2009, 51.1% of the T2DM respondents received oral antidiabetic medications alone, 12.5% received insulin plus oral antidiabetic agents, 9.6% received insulin alone, and 26.8% received no diabetes medications. The gene discussed is INS; the disease is diabetes mellitus.